These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 16423348

  • 1. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
    Irony-Tur-Sinai M, Grigoriadis N, Lourbopoulos A, Pinto-Maaravi F, Abramsky O, Brenner T.
    Exp Neurol; 2006 Mar; 198(1):136-44. PubMed ID: 16423348
    [Abstract] [Full Text] [Related]

  • 2. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
    Zhang GX, Yu S, Gran B, Li J, Calida D, Ventura E, Chen X, Rostami A.
    J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
    [Abstract] [Full Text] [Related]

  • 3. Immunomodulation of EAE by alpha-fetoprotein involves elevation of immune cell apoptosis markers and the transcription factor FoxP3.
    Irony-Tur-Sinai M, Grigoriadis N, Tsiantoulas D, Touloumi O, Abramsky O, Brenner T.
    J Neurol Sci; 2009 Apr 15; 279(1-2):80-7. PubMed ID: 19171355
    [Abstract] [Full Text] [Related]

  • 4. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
    Luccarini I, Ballerini C, Biagioli T, Biamonte F, Bellucci A, Rosi MC, Grossi C, Massacesi L, Casamenti F.
    Exp Neurol; 2008 May 15; 211(1):214-26. PubMed ID: 18346732
    [Abstract] [Full Text] [Related]

  • 5. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis.
    Ford ML, Evavold BD.
    Eur J Immunol; 2004 Feb 15; 34(2):388-97. PubMed ID: 14768043
    [Abstract] [Full Text] [Related]

  • 6. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
    Fu YF, Zhu YN, Ni J, Zhong XG, Tang W, Re YD, Shi LP, Wan J, Yang YF, Yuan C, Nan FJ, Lawson BR, Zuo JP.
    J Pharmacol Exp Ther; 2006 Nov 15; 319(2):799-808. PubMed ID: 16914558
    [Abstract] [Full Text] [Related]

  • 7. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK, Culbertson N, Rich C, LaTocha D, Buenafe AC, Huan J, Link J, Wands JM, Born WK, Offner H, Bourdette DN, Burrows GG, Vandenbark AA.
    J Neurosci Res; 2004 Sep 01; 77(5):670-80. PubMed ID: 15352213
    [Abstract] [Full Text] [Related]

  • 8. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.
    Morini M, Roccatagliata L, Dell'Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D, Pfeffer U, Marchese M, Noonan D, Mancardi G, Albini A, Uccelli A.
    J Neuroimmunol; 2004 Mar 01; 148(1-2):146-53. PubMed ID: 14975595
    [Abstract] [Full Text] [Related]

  • 9. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice.
    Khare M, Mangalam A, Rodriguez M, David CS.
    J Neuroimmunol; 2005 Dec 01; 169(1-2):1-12. PubMed ID: 16194572
    [Abstract] [Full Text] [Related]

  • 10. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ, Truong JJ, Kerr BJ.
    Pain; 2009 Jan 01; 141(1-2):156-64. PubMed ID: 19084337
    [Abstract] [Full Text] [Related]

  • 11. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C, Pedotti R, Baggi F, Ubiali F, Gallo B, Nava S, Bigini P, Barbera S, Fumagalli E, Mennini T, Vezzani A, Rizzi M, Coleman T, Cerami A, Brines M, Ghezzi P, Bianchi R.
    J Neuroimmunol; 2006 Mar 01; 172(1-2):27-37. PubMed ID: 16337691
    [Abstract] [Full Text] [Related]

  • 12. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
    Li O, Liu JQ, Zhang H, Zheng P, Liu Y, Bai XF.
    Scand J Immunol; 2006 Aug 01; 64(2):117-24. PubMed ID: 16867156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis.
    De Paula ML, Rodrigues DH, Teixeira HC, Barsante MM, Souza MA, Ferreira AP.
    Int Immunopharmacol; 2008 Sep 01; 8(9):1291-7. PubMed ID: 18602076
    [Abstract] [Full Text] [Related]

  • 17. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Palaszynski KM, Liu H, Loo KK, Voskuhl RR.
    J Neuroimmunol; 2004 Apr 01; 149(1-2):84-9. PubMed ID: 15020068
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.
    Castelo-Branco G, Stridh P, Guerreiro-Cacais AO, Adzemovic MZ, Falcão AM, Marta M, Berglund R, Gillett A, Hamza KH, Lassmann H, Hermanson O, Jagodic M.
    Neurobiol Dis; 2014 Nov 01; 71():220-33. PubMed ID: 25149263
    [Abstract] [Full Text] [Related]

  • 20. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P, Gutierrez-Mecinas M, Prado J, Usero L, Roura-Mir C, Giralt M, Hidalgo J, García A.
    Exp Neurol; 2014 Jan 01; 251():58-71. PubMed ID: 24211383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.